GlaxoSmithKline

JP Morgan raises target price on GSK ShareCast13:45
Citi lifts GSK target price but keeps neutral stance after rally Proactive Investors (US)12:17
‘Old school’ UK stocks like Lloyds, GSK, and Vodafone are making a huge comeback. Here are 2 to … Motley Fool (UK)08:14
China's Cde accepts GSK's regulatory filing for RSV vaccine ShareCast07:50
Broker tips: Dunelm, GSK, Greggs ShareCast15:44
Invasive fungal infections market to witness upsurge in growth at a CAGR of 11.4% (in the US)… PR Newswire (Press Release)22:33

Latest News

Yesterday
GSK Rsv vaccine Arexvy accepted for review in China for adults over 60 London South East10:23 10-Feb-26
China's Cde accepts GSK's regulatory filing for Rsv vaccine ShareCast07:50 10-Feb-26
GSK: China's Cde To Review Regulatory Application For Arexvy RTT News07:48 10-Feb-26
In the last 7 days
Invasive Fungal Infections Market to Witness Upsurge in Growth at a CAGR of 11.4% (in the US)… PR Newswire (Press Release)22:33 9-Feb-26
Broker tips: Dunelm, GSK, Greggs ShareCast15:44 9-Feb-26
JP Morgan raises target price on GSK ShareCast13:45 9-Feb-26
Citi lifts GSK target price but keeps neutral stance after rally Proactive Investors (US)12:17 9-Feb-26
GlaxoSmithKline Pharma Q3 profit up 29 pc at Rs 296 cr The Business Standard11:12 9-Feb-26
Q3 Results Today Live: BSE, Zydus Lifesciences, Aurobindo Pharma, Linde India, Axiscades Tech, GlaxoSmithKline Pharma,… The Hindu Business Line04:06 9-Feb-26
Q3 results: Pfizer, Zydus Lifesciences, Aurobindo Pharma, 181 more on Feb 9 The Business Standard02:25 9-Feb-26
‘Old school’ UK stocks like Lloyds, GSK, and Vodafone are making a huge comeback. Here are 2 to … Motley Fool (UK)08:14 8-Feb-26
GSK Gets EU Approval for Expanded Use of Nucala in COPD Zacks17:50 6-Feb-26
In brief: GSK Chair Jonathan Symonds buys GBP53,000 in shares London South East16:20 6-Feb-26
Director dealings: GSK chairman raises stake London South East15:08 6-Feb-26
GSK’s Nucala green lit for COPD in expanded EU approval European Pharmaceutical Review12:26 6-Feb-26
ShoreCap says GSK has cracked it and the £40bn prize is now in sight Proactive Investors (UK)10:15 6-Feb-26
New Oxford-led initiative launches to train future leaders in transformative technologies for pharmaceutical research University of Oxford09:27 6-Feb-26
EU regulator greenlights GSK lung disease therapy Nucala London South East08:42 6-Feb-26
London briefing: UK house prices rise more than expected in January London South East08:01 6-Feb-26
EU gives GSK's Nucala green light for use in uncontrolled COPD ShareCast07:46 6-Feb-26
GSK’s H5N1 mRNA Flu Vaccine Trial Reaches Completion: What Investors Should Watch Next TipRanks16:32 5-Feb-26
GSK Earnings: Strong Performance Across Specialty Medicines Boosts Full-Year Outlook Morningstar15:09 5-Feb-26
Pharma chameleon: GSK celebrates post-Zantac comeback Punchline Magazine10:37 5-Feb-26
GSK shares healthy after annual results interactive investor10:07 5-Feb-26
GSK sees profits rise but fears slowdown in growth Yorkshire Post08:07 5-Feb-26
GSK’s oncology and HIV drugs drive 7% sales rise in 2025 Pharmaceutical Technology18:41 4-Feb-26
GSK beat the numbers, but the real story was the guidance Proactive Investors (UK)15:31 4-Feb-26
As CEO, Luke Miels wants GSK to be more ‘product-centric’ FiercePharma14:51 4-Feb-26
GSK's Q4 Earnings & Sales Beat Estimates, Stock Up on '26 Outlook Zacks14:43 4-Feb-26
GSK Bets On New Launches And R&D Acceleration As Sales Headwinds Remain Scrip Pharma Intelligence14:10 4-Feb-26
GSK Stock Smashes 52-Week High On Strong Quarter, Dividend Hike Benzinga13:20 4-Feb-26
GSK delivers in new CEO Miels' first financial update pharmaphorum13:17 4-Feb-26
GSK (GSK) Surpasses Q4 Earnings and Revenue Estimates Zacks13:11 4-Feb-26
GSK starts to show real profit improvement Investors Chronicle12:56 4-Feb-26
GSK boosted by specialty drugs, end to Zantac fallout France 2412:29 4-Feb-26
London market midday: FTSE 100 strengthens as Beazley and GSK rise London South East12:11 4-Feb-26
FTSE shrugs off AI chaos Investors Chronicle12:10 4-Feb-26
AI hits stocks & GSK: Markets live blog Investors Chronicle10:53 4-Feb-26
GSK posts higher profits but indicates sales growth to slow in 2026 Evening Standard09:18 4-Feb-26
GSK optimistic for 2026 after fourth-quarter results beat forecast London South East08:58 4-Feb-26
GSK expects softer sales growth for 2026 RTE08:54 4-Feb-26
GSK expects softer 2026 sales growth as new CEO Miels prepares change in course Yahoo! UK & Ireland08:47 4-Feb-26
GSK Targets Long-Term Growth as Late-Stage Assets Near Commercialization Investing.com UK08:27 4-Feb-26
GSK delivers solid 2025 results, reaffirms growth outlook for 2026 Proactive Investors (US)08:18 4-Feb-26
London briefing: Zurich agrees terms for GBP8.0 billion Beazley offer London South East08:07 4-Feb-26
GSK sees slower sales growth in 2026 as patent loss looms ShareCast07:54 4-Feb-26
GSK sees turnover growth slowing in FY26, DCC Q3 adjusted operating profits grow ShareCast07:42 4-Feb-26
GSK forecasts slower sales growth in 2026 Yahoo! US07:13 4-Feb-26
London market early call: FTSE 100 to rise with GSK results due London South East06:56 4-Feb-26
In the last month
Wednesday preview: GSK results among the highlights ShareCast16:01 3-Feb-26
Why GSK (GSK) is a Top Value Stock for the Long-Term Zacks15:46 3-Feb-26
Insights Ahead: GSK's Quarterly Earnings Benzinga14:15 3-Feb-26
GSK full-year earnings: can the pharma giant deliver on post... IG11:48 3-Feb-26
GSK to cut 50 jobs at Stevenage site as part of overhaul The Comet, Hertfordshire10:05 3-Feb-26
GSK kicks out of Wave's AATD programme pharmaphorum09:49 3-Feb-26
Overhaul sees GSK slash 350 R&D jobs Business Plus Online07:35 3-Feb-26
Wave Life Sciences Reclaims Rare Disease Drug From GSK, Targets Faster FDA Path Benzinga19:19 2-Feb-26
GSK to cut up to 350 R&D jobs across UK, US ShareCast17:37 2-Feb-26
Drugs giant to axe up to 350 R&D jobs across the US and UK Yahoo! UK & Ireland16:22 2-Feb-26
GSK cutting jobs in UK and US as part of ongoing R&D changes The Independent14:42 2-Feb-26
GSK walks away from pioneering Wave RNA editing drug BioPharma Dive14:29 2-Feb-26
Week Ahead: GSK, BT, Shell, Vodafone, Anglo American interactive investor13:29 2-Feb-26
Top FTSE 100 Index shares to watch: BT Group, Vodafone, Shell, GSK Invezz08:25 30-Jan-26
Here's Why GSK (GSK) is a Strong Growth Stock Zacks15:55 28-Jan-26
FTSE 100: European stocks dragged down as dollar rallies and gold exert pull Proactive Investors (US)11:07 28-Jan-26
Jan. 27 Business Watch: Vioneo moves project to China; GSK to buy Rapt Therapeutics for $2.2 billion Chemical & Engineering News20:05 27-Jan-26
Broker tips: Zotefoams, Burberry, AstraZeneca, GSK ShareCast15:57 27-Jan-26
Here's Why GSK (GSK) is a Strong Momentum Stock Zacks15:56 27-Jan-26
Citi starts AstraZeneca at 'buy', takes 'neutral' stance on GSK ShareCast13:34 27-Jan-26
GSK’s Arexvy RSV vaccine receives expanded EC approval for use in adults PMLiVE13:08 27-Jan-26
GSK, Takeda among wave of new licensees in booming drug delivery space IAM07:19 27-Jan-26
Korea's Alteogen inks $265 M deal with GSK to develop subcutaneous formulation of Dostarlimab BioSpectrum Asia06:51 27-Jan-26
GSK's Rsv treatment, Arexvy, secures approval for wider use in EU London South East08:30 26-Jan-26
London briefing: GSK wins EU nod for Rsv shot; Spire in early talks London South East08:09 26-Jan-26
GSK: Arexvy Vaccine Receives European Commission Approval For Use In All Adults RTT News07:52 26-Jan-26
EU clears GSK's Rsv vaccine for use in all adults, Spire confirms early talks with Bridgepoint and Triton ShareCast07:29 26-Jan-26
GSK vaccine given green light for all adults in Europe London South East07:29 26-Jan-26
The 5 most popular FTSE 100 stocks on AJ Bell to begin 2026 Motley Fool (UK)06:56 26-Jan-26
Weekly Buzz: Iobt Slashes Jobs; GSK To Acquire rapt; Cort's Ovarian Cancer Study Meets Goals RTT News15:05 23-Jan-26
In brief: GSK drug approved in China to treat uncontrolled asthma London South East10:18 23-Jan-26
Pharma Bets Big on AI Platforms with Flurry of New Year... Genetic Engineering and Biotechnology News19:50 22-Jan-26
GSK Halts Early-Stage Sickle Cell Study, Tweaking the Risk Profile of Its Rare Disease Pipeline TipRanks16:31 22-Jan-26
ii view: GSK makes exciting food allergy acquisition interactive investor14:37 22-Jan-26
GSK's Rockville R&D campus slated for big renovation Washington Business Journal20:29 21-Jan-26
GSK to Boost Respiratory & Immunology Pipeline With $2.2B RAPT Buyout Zacks16:26 21-Jan-26
GSK Velu appointed Chairman of Ficci Tamil Nadu State Council The Hindu Business Line15:20 21-Jan-26
GSK Awards $2M in COiMMUNITY Initiative Grants to Help Close Vaccination Gaps, Commits $3M for… Business Wire (Press Release)15:10 21-Jan-26
Sherry Knowles IAM14:26 21-Jan-26
GSK acquires food allergy firm Rapt Therapeutics for $2.2bn European Pharmaceutical Review13:02 21-Jan-26
In brief: Rtw Biotech welcomes GSK deal to buy rapt Therapeutics London South East11:38 21-Jan-26
GSK and Shionogi agree to replace Pfizer's stake in ViiV Healthcare BioSpectrum Asia06:00 21-Jan-26
Why Rapt Therapeutics Stock Soared Today The Motley Fool22:42 20-Jan-26
GSK gaining Rapt’s allergy drug in $2.2B M&A BioWorld22:26 20-Jan-26
GSK licenses Alteogen enzyme in bid to develop subQ Jemperli FiercePharma19:51 20-Jan-26
BMY vs GSK: Which Biopharma Giant Has Better Prospects for Now? Zacks19:50 20-Jan-26
GSK to Acquire Rapt for $2.2B, Adding Food Allergy Candidate to... Genetic Engineering and Biotechnology News19:42 20-Jan-26
RAPT Therapeutics Jumps to Deal Level as GSK Acquisition Resets the Valuation Investing.com UK18:07 20-Jan-26
GSK makes $2.2 billion swoop for RAPT Therapeutics’ food allergy drug Investing.com18:01 20-Jan-26
GSK on the simplification of the ViiV Healthcare shareholding structure Slaughter and May (Press Release)16:54 20-Jan-26
GSK Strikes $2.2bn Deal For RAPT And Its Xolair Challenger Scrip Pharma Intelligence15:48 20-Jan-26
Pfizer sells its stake in GSK's ViiV for $1.9B, with Shionogi upping its ante in the… FiercePharma15:17 20-Jan-26
Under £19, here’s why GSK’s share price looks cheap to me anywhere below £42.92 Motley Fool (UK)15:08 20-Jan-26
GSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 Million Business Wire (Press Release)14:01 20-Jan-26
ViiV ownership shifts as Pfizer sells its stake pharmaphorum13:34 20-Jan-26
A&O Shearman Steers GSK's $2.2B Rapt Therapeutics Deal Law36012:56 20-Jan-26
RAPT Therapeutics shares surge 64% as GSK agrees $2.2B acquisition Invezz12:45 20-Jan-26
GSK acquires RAPT Therapeutics for $2.2bn Pharmaceutical Technology12:38 20-Jan-26
GSK to buy food allergy drug maker rapt in $2.2bn deal Yahoo! UK & Ireland12:38 20-Jan-26
Scientists May Have Found The Body’s ‘Brake Pedal’ For Inflammation Study Finds12:08 20-Jan-26
Ibstock & GSK: Markets live blog Investors Chronicle11:37 20-Jan-26
GSK to Acquire RAPT Therapeutics in Cash Merger TipRanks11:34 20-Jan-26
GSK to acquire US biotech group for $2.2bn City AM11:02 20-Jan-26
GSK To Acquire rapt Therapeutics In $2.2 Billion Bet On Food Allergy Breakthrough Benzinga11:00 20-Jan-26
GSK reaches $2.2bn deal to buy food allergy biotech RAPT pharmaphorum10:21 20-Jan-26
RAPT Therapeutics stock soars 64% on GSK’s $2.2 billion acquisition offer Investing.com10:09 20-Jan-26

      
            
      
    view more headlines
   
      
      
      
10 Feb 10:23
   

GlaxoSmithKline News

NewsNow aims to be the world's most accurate and comprehensive aggregator of GlaxoSmithKline news, covering the latest share price, company announcements, vaccine trials, product news and more from the best online publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.

GlaxoSmithKline

Latest News

GlaxoSmithKline News

Pharmaceuticals Top Stories

UK Top Stories

World Top Stories